ACOR
Vanguard Group’s Acorda Therapeutics, Inc. ACOR Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-19,260
| Closed | -$254K | – | 4519 |
|
2024
Q1 | $254K | Buy |
19,260
+8,452
| +78% | +$112K | ﹤0.01% | 4140 |
|
2023
Q4 | $163K | Buy |
10,808
+74
| +0.7% | +$1.12K | ﹤0.01% | 4248 |
|
2023
Q3 | $161K | Buy |
+10,734
| New | +$161K | ﹤0.01% | 4288 |
|
2023
Q2 | – | Sell |
-159,778
| Closed | -$93.6K | – | 4598 |
|
2023
Q1 | $93.6K | Buy |
159,778
+1,459
| +0.9% | +$855 | ﹤0.01% | 4414 |
|
2022
Q4 | $121K | Buy |
158,319
+3,040
| +2% | +$2.33K | ﹤0.01% | 4372 |
|
2022
Q3 | $46K | Sell |
155,279
-2,782
| -2% | -$824 | ﹤0.01% | 4550 |
|
2022
Q2 | $73K | Sell |
158,061
-183,484
| -54% | -$84.7K | ﹤0.01% | 4566 |
|
2022
Q1 | $549K | Hold |
341,545
| – | – | ﹤0.01% | 4384 |
|
2021
Q4 | $817K | Hold |
341,545
| – | – | ﹤0.01% | 4316 |
|
2021
Q3 | $1.57M | Buy |
341,545
+1,064
| +0.3% | +$4.89K | ﹤0.01% | 4130 |
|
2021
Q2 | $1.62M | Buy |
340,481
+68,240
| +25% | +$325K | ﹤0.01% | 4031 |
|
2021
Q1 | $1.33M | Sell |
272,241
-1,547,888
| -85% | -$7.53M | ﹤0.01% | 3949 |
|
2020
Q4 | $1.26M | Sell |
1,820,129
-1,042,304
| -36% | -$719K | ﹤0.01% | 3773 |
|
2020
Q3 | $1.47M | Sell |
2,862,433
-1,145,314
| -29% | -$590K | ﹤0.01% | 3575 |
|
2020
Q2 | $2.94M | Sell |
4,007,747
-423,251
| -10% | -$311K | ﹤0.01% | 3318 |
|
2020
Q1 | $4.14M | Sell |
4,430,998
-612,640
| -12% | -$572K | ﹤0.01% | 3051 |
|
2019
Q4 | $10.3M | Sell |
5,043,638
-932,599
| -16% | -$1.9M | ﹤0.01% | 2845 |
|
2019
Q3 | $17.2M | Sell |
5,976,237
-216,034
| -3% | -$620K | ﹤0.01% | 2557 |
|
2019
Q2 | $47.5M | Sell |
6,192,271
-677,091
| -10% | -$5.19M | ﹤0.01% | 2127 |
|
2019
Q1 | $91.3M | Buy |
6,869,362
+766,007
| +13% | +$10.2M | ﹤0.01% | 1795 |
|
2018
Q4 | $95.1M | Buy |
6,103,355
+718,819
| +13% | +$11.2M | ﹤0.01% | 1706 |
|
2018
Q3 | $106M | Buy |
5,384,536
+545,689
| +11% | +$10.7M | ﹤0.01% | 1775 |
|
2018
Q2 | $139M | Buy |
4,838,847
+450,659
| +10% | +$12.9M | 0.01% | 1595 |
|
2018
Q1 | $104M | Buy |
4,388,188
+11,599
| +0.3% | +$274K | ﹤0.01% | 1695 |
|
2017
Q4 | $93.9M | Buy |
4,376,589
+116,531
| +3% | +$2.5M | ﹤0.01% | 1752 |
|
2017
Q3 | $101M | Sell |
4,260,058
-48,102
| -1% | -$1.14M | ﹤0.01% | 1712 |
|
2017
Q2 | $84.9M | Buy |
4,308,160
+168,571
| +4% | +$3.32M | ﹤0.01% | 1763 |
|
2017
Q1 | $86.9M | Buy |
4,139,589
+233,575
| +6% | +$4.91M | ﹤0.01% | 1739 |
|
2016
Q4 | $73.4M | Sell |
3,906,014
-116,740
| -3% | -$2.19M | ﹤0.01% | 1790 |
|
2016
Q3 | $84M | Sell |
4,022,754
-245,925
| -6% | -$5.13M | ﹤0.01% | 1676 |
|
2016
Q2 | $109M | Buy |
4,268,679
+759,257
| +22% | +$19.4M | 0.01% | 1462 |
|
2016
Q1 | $92.8M | Buy |
3,509,422
+225,649
| +7% | +$5.97M | 0.01% | 1535 |
|
2015
Q4 | $140M | Buy |
3,283,773
+89,986
| +3% | +$3.85M | 0.01% | 1228 |
|
2015
Q3 | $84.7M | Buy |
3,193,787
+78,398
| +3% | +$2.08M | 0.01% | 1555 |
|
2015
Q2 | $104M | Buy |
3,115,389
+129,614
| +4% | +$4.32M | 0.01% | 1496 |
|
2015
Q1 | $99.4M | Buy |
2,985,775
+142,562
| +5% | +$4.74M | 0.01% | 1499 |
|
2014
Q4 | $116M | Buy |
2,843,213
+15,589
| +0.6% | +$637K | 0.01% | 1309 |
|
2014
Q3 | $95.8M | Buy |
2,827,624
+45,705
| +2% | +$1.55M | 0.01% | 1386 |
|
2014
Q2 | $93.8M | Buy |
2,781,919
+8,778
| +0.3% | +$296K | 0.01% | 1438 |
|
2014
Q1 | $105M | Buy |
2,773,141
+117,545
| +4% | +$4.46M | 0.01% | 1319 |
|
2013
Q4 | $77.5M | Buy |
2,655,596
+127,206
| +5% | +$3.71M | 0.01% | 1487 |
|
2013
Q3 | $86.7M | Buy |
2,528,390
+75,277
| +3% | +$2.58M | 0.01% | 1337 |
|
2013
Q2 | $80.9M | Buy |
+2,453,113
| New | +$80.9M | 0.01% | 1309 |
|